MAWA
VRTX icon

Moss Adams Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Moss Adams Wealth Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$427K Buy
957
+109
+13% +$50.8K 0.03% 156
2025
Q4 		$385K Buy
848
+220
+35% +$94.8K 0.03% 164
2025
Q3 		$246K Sell
628
-123
-16% -$51.4K 0.02% 213
2025
Q2 		$334K Sell
751
-112
-13% -$51.6K 0.03% 183
2025
Q1 		$419K Buy
863
+332
+63% +$155K 0.04% 125
2024
Q4 		$214K Sell
531
-32
-6% -$14.8K 0.02% 192
2024
Q3 		$262K Buy
563
+40
+8% +$19.2K 0.03% 162
2024
Q2 		$245K Buy
+523
New +$227K 0.03% 142

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Moss Adams Wealth Advisors's VRTX Position: Q1 2026 in Review

Moss Adams Wealth Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 13% in Q1 2026, buying an estimated $50.8K and bringing the position to 957 shares worth $427K. The position accounts for 0.03% of the portfolio, ranked #156.

Moss Adams Wealth Advisors first reported a position in VRTX in Q2 2024 and has held it in 8 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Moss Adams Wealth Advisors held 957 shares of Vertex Pharmaceuticals worth $427K as of Q1 2026.
  • Moss Adams Wealth Advisors bought 109 Vertex Pharmaceuticals shares in Q1 2026, an estimated $50.8K.
  • Vertex Pharmaceuticals made up 0.03% of Moss Adams Wealth Advisors's portfolio in Q1 2026, its #156 holding.
  • Moss Adams Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Moss Adams Wealth Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.